Universidad del SalvadorBuenos Aires, Argentina
Disclosure information not submitted.
ORF16-08 - Efficacy and Safety of Once-Weekly Canvuparatide in Patients with Hypoparathyroidism: Results from Avail, a Phase 2 Randomized Clinical Trial
Saturday, June 13, 20263:00 PM - 3:15 PM CT